J Med Cases
Journal of Medical Cases, ISSN 1923-4155 print, 1923-4163 online, Open Access
Article copyright, the authors; Journal compilation copyright, J Med Cases and Elmer Press Inc
Journal website http://www.journalmc.org

Case Report

Volume 6, Number 8, August 2015, pages 346-349


Pyogenic Liver Abscess Mimicking Liver Neoplasm on Computed Tomography Scan in a Patient With Elevated CA 19-9

Moustafa Elsheshtawya, b, Zeyar Theta

aDepartment of Medicine, Coney Island Hospital, Brooklyn, NY 11235, USA
bCorresponding Author: Moustafa Elsheshtawy, Department of Medicine, Coney Island Hospital, 2601 Ocean Parkway, Room 4N98, Brooklyn, NY 11235, USA

Manuscript accepted for publication July 01, 2015
Short title: Liver Abscess Mimicking Liver Neoplasm
doi: http://dx.doi.org/10.14740/jmc2238w

Abstract▴Top 

Pyogenic liver abscess (PLA) presentation on computer tomography (CT) scan depends mainly on the degree of maturation and internal contents, but rarely presents similarly to primary liver cancer (PLC) or hepatic metastasis. However, distinguishing PLA from PLC can be a challenge, and several cases were reported previously where tumor markers helped in this differentiation. We present a rare case of PLA with radiological findings similar to PLC or liver metastasis on CT scan in a patient with elevated tumor marker, carbohydrate antigen (CA) 19-9. This case illustrates that a combination of risk factors and clinical findings including localizing symptoms, fever, leukocytosis and tumor markers has to accompany image findings to reach an appropriate differentiation in a query case of hepatic lesion.

Keywords: Liver abscess; Liver cancer; Computed tomography; Tumor marker

Introduction▴Top 

Pyogenic liver abscess (PLA) was found to be associated with cancers of different origins. Although inflammation-mediated carcinogenesis can be carried out over a considerable time, certain cancers can masquerade as liver abscesses either through spontaneous tumor necrosis or biliary obstruction superimposed by bacterial infection caused by tumor thrombi [1, 2]. As previously published in the American Association for the Study of Liver Diseases (AASLD) and the Asian Pacific Association for the Study of the Liver (APASL) guidelines, computed tomography (CT) imaging is sufficient to confirm the diagnosis of hepatocellular carcinoma (HCC) without the need for histopathologic confirmation [3, 4]. We present a rare case of PLAs caused by Streptococcus constellatus with similar radiological features to liver neoplasm on contrast enhanced CT scan in a patient found to have elevated tumor marker carbohydrate antigen (CA) 19-9.

Case Report▴Top 

An 88-year-old female presented to the emergency department for evaluation of upper respiratory tract infection non-specific symptoms which started 4 days ago. The patient had a medical history significant for diabetes mellitus, colonic diverticulosis and depression.

The patient was found to have systemic inflammatory response syndrome including fever and respiratory distress. Electrocardiogram showed new onset atrial fibrillation with rapid ventricular response.

On admission, laboratory results revealed high anion gap metabolic acidosis and leukocytosis as shown (Table 1). Urine analysis was normal. Chest and abdomen X-rays were unremarkable.

Table 1.
Click to view
Table 1. Laboratory Data on Admission (in SI Units)
 

An ultrasound of the abdomen showed abnormal echotexture related to hepatic parenchymal disease with two hypodense heterogeneous mass lesions identified in the right hepatic lobe measuring 3 × 3.8 cm and 5.3 × 3.6 cm (Fig. 1A). Non-specific gallbladder wall thickening (5 mm) without gallstones, intrahepatic biliary ductal dilatation and normal common bile duct caliber were also noted in the ultrasound. The patient was admitted to the medical intensive care unit (ICU) for management of diabetic ketoacidosis (DKA) and sepsis.

Figure 1.
Click for large image
Figure 1. Hepatic abscess caused by Streptococcus constellatus mimicking HCC or hepatic metastasis. (A) Abdomen US demonstrating two hypodense heterogenous right hepatic lobe lesions measuring 3 × 3.8 cm and 5.3 × 3.6 cm. (B) Initial contrast enhancing CT scan illustrating multifocal multi-septated enhancing lesions. (C) Contrast enhanced CT showing improvement in hepatic multi-septated abscesses following 4 weeks of antibiotic therapy.

Blood cultures taken on admission revealed Streptococcus constellatus growth in a total of four bottles. Because the nature of the organism was suggestive of disseminated abscesses formation, a CT scan of the chest, abdomen and pelvis was performed. CT scans with contrast revealed low density lesions involving both the right and left lobes of the liver with enhancement of septae (Fig. 1B). Differential diagnosis included cholangiocarcinoma, metastatic liver lesions or multi-centric HCC. It is believed that certain cancers can masquerade as liver abscesses either through spontaneous tumor necrosis or biliary obstruction superimposed by bacterial infection caused by tumor thrombi. Based on the radiological interpretation and elevated CA 19-9, impression of primary liver cancer (PLC) with superimposed bacteremia was pursued.

An initial liver biopsy was done and the result was inconclusive; however, the sample showed benign hepatic tissue with no evidence of malignant cells. A repeat liver biopsy aspirated pus-like material following 2 weeks of intravenous antibiotics. Gram staining showed many gram positive cocci with no growth at that time. A diagnosis of liver abscesses caused by Streptococcus constellatus resulted from portal pyemia secondary to perforated micro-abscess of diverticulae was concluded.

The patient was started empirically on broad spectrum antibiotics (vancomycin, pipracillin-tozabactam and metronidazole) while in the ICU. She was also started on anticoagulation therapy for atrial fibrillation. After a total of 4 weeks of intravenous antibiotics, a CT scan of the abdomen with contrast showed improvement in the size and number of hepatic lesions (Fig. 1C). Unfortunately, the patient’s condition was further complicated with Clostridium difficile colitis, and she expired in the hospital during the treatment.

Discussion▴Top 

Differentiating PLC from PLA can be a real challenge. Criteria including male gender, hepatitis B and/or hepatitis C infection, and cirrhosis were provided to be a meaningful tool in distinguishing the two diagnoses [1]. Non-invasive radiological findings in CT or MRI of wash-in and wash-out were deemed to have a high yield specificity and acceptable sensitivity in diagnosing HCC [4]. However, in our case, the PLAs caused by Streptococcus constellatus presented with similar radiological features to liver neoplasm on contrast enhanced CT scan in a patient found to have elevated tumor marker CA 19-9.

Incidences of PLA mimicking PLC, including HCC in 80-90% of all cases, and intrahepatic cholangiocarcinoma (ICC), were reported in the literature. Such mimicry led to, in many cases, incorrect diagnosis and treatment including unnecessary surgery [5-9].

In one report, the absence of liver cirrhosis on CT and MRI along with normal liver functions was not enough evidence to exclude HCC as a diagnosis. The absence of fever and leukocytosis resulted in hepatic abscess exclusion, and the patient was exposed to unnecessary surgery [6]. In a contrary case, PLA was reported in a cirrhotic patient who presented with sepsis of unclear etiology [9].

Radiological presentation of hepatic abscesses ranges from hypodense rim-enhancing well-circumscribed cystic lesion to a heterogeneously mosaic enhancing mass [7, 10]. Enhancing contrast CT is considered one of the gold standards to differentiate PLA from PLC or hepatic metastasis [7, 11, 12]. While most liver hypervascular liver tumors (as HCC) show greatest background conspicuity on late arterial phase, hypovascular tumors (as liver metastasis) are usually seen well on the portal venous or equilibrium/delayed phase of contrast [13].

HCC usually presents with dynamic radiological changes such as early arterial enhancement and delayed wash-out, well-defined capsule with delayed enhancement or even a mosaic pattern of enhancement [11, 12]. Application of dynamic imaging criteria to diagnose HCC was suggested only in cirrhotic patients regardless of etiology and patients with chronic hepatopathy [3]. Imaging diagnosis of HCC is a worldwide accepted guideline for HCC diagnosis in cirrhotic patients [4]. Pseudo-capsule appearance of HCC on portal venous phase can mimic unilocular abscess [14]. Cystic HCC (unilocular and multifocal), although rare, was described previously in the literature in non-cirrhotic patients [8, 15]. Cystic hepatic lesions in the setting of pyrexia and leukocytosis should always raise suspicion for abscess [5].

Contrast enhanced ultrasounds were dropped from AASLD recommendations to diagnose PLC due to the potential risk of misdiagnosis of ICC as HCC [3]. Additionally, biopsies were also excluded from HCC diagnosis guidelines by the AASLD and APASL for small, atypical lesions in view of high false-negative rate and should be used after careful evaluation in selected cases only without wash-in or wash-out findings on two imaging modalities [4].

ICC can present as periductal, intraductal or intrahepatic mass forming [13]. Mass forming ICC usually appears homogeneous, low-attenuated mass with irregular peripheral enhancement or a retracted capsule on CT [16]. There are currently no guidelines posted for ICC screening in high risk groups, although hepatobiliary MRI and CA 19-9 are frequently used without proven benefit [16, 17].

CT scan was shown to be effective in staging and following liver metastases and is utilized in many cancer centers [18].

Interestingly, HCC can present as PLA initially which predicts a worse prognosis [19]. In a case series study, elevated alpha fetoprotein was used to diagnose HCC when symptoms including fever, chills, right upper quadrant abdominal pain, nausea, vomiting, weight loss and diarrhea were associated with PLC in patients that presented initially as PLA [20]. A combination of elevated serum CA 19-9 with polysomy identified by fluorescence in situ hybridization (FISH) raise a high index of suspicion of malignancy in patients with underlying primary sclerosing cholangitis even without mass on imaging [21]. Fever and/or leukocytosis, even though not common, were previously reported to be associated with tumor-associated infections [22].

Conclusion

Hepatic abscess presentation on CT scan depends mainly on the degree of maturation and internal contents, but rarely present similarly to PLC or hepatic metastasis [23]. According to AASLD and APASL guidelines, CT imaging is sufficient to confirm diagnosis of HCC, as a PLC, without need for histopathological confirmation [4]. However, clinical presentation and laboratory findings should always be taken into consideration when interpreting radiological data. CT or ultrasonography-guided biopsy should always be used in rare instances of any doubt between the two entities.

Acknowledgement

The authors wish to express their sincere gratitude to the research department in Coney Island Hospital for all their help and support.

Author Contributions

All authors listed have contributed sufficiently to the project to be included as authors, and all those who are qualified to be authors are listed in the author byline.

Funding

None.

Conflict of Interest

The authors declare that they do not have a conflict of interest.


References▴Top 
  1. Yeh TS, Jan YY, Jeng LB, Chen TC, Hwang TL, Chen MF. Hepatocellular carcinoma presenting as pyogenic liver abscess: characteristics, diagnosis, and management. Clin Infect Dis. 1998;26(5):1224-1226.
    doi pubmed
  2. Coussens LM, Werb Z. Inflammation and cancer. Nature. 2002;420(6917):860-867.
    doi pubmed
  3. Ricke J, Seidensticker M, Mohnike K. Noninvasive diagnosis of hepatocellular carcinoma in cirrhotic liver: current guidelines and future prospects for radiological imaging. Liver Cancer. 2012;1(1):51-58.
    doi pubmed
  4. Bruix J, Sherman M. Management of hepatocellular carcinoma: an update. Hepatology. 2011;53(3):1020-1022.
    doi pubmed
  5. Falidas E, Pazidis A, Anyfantakis G, Vlachos K, Goudeli C, Villias C. Multicystic hepatocarcinoma mimicking liver abscess. Case Rep Surg. 2013;2013:374905.
    doi
  6. Kim JW, Shin SS, Heo SH, Lim HS, Hur YH, Kim JH. Hepatic abscess mimicking hepatocellular carcinoma in a patient with alcoholic liver disease. Clin Mol Hepatol. 2013;19(4):431-434.
    doi pubmed
  7. Brown KT, Gandhi RT, Covey AM, Brody LA, Getrajdman GI. Pylephlebitis and liver abscess mimicking hepatocellular carcinoma. Hepatobiliary Pancreat Dis Int. 2003;2(2):221-225.
    pubmed
  8. Ham H, Kim HY, Seo KJ, Lee SL, Kim CW. Cholangiocarcinoma with a paraneoplastic leukemoid reaction mimicking a pyogenic liver abscess. Korean J Intern Med. 2015;30(1):110-113.
    doi pubmed
  9. Chou YP, Changchien CS, Chiu KW, Kuo CM, Kuo FY, Kuo CH. Salmonellosis with liver abscess mimicking hepatocellular carcinoma in a diabetic and cirrhotic patient: a case report and review of the literature. Liver Int. 2006;26(4):498-501.
    doi pubmed
  10. Vachha B, Sun MR, Siewert B, Eisenberg RL. Cystic lesions of the liver. AJR Am J Roentgenol. 2011;196(4):W355-366.
    doi pubmed
  11. Seeto RK, Rockey DC. Pyogenic liver abscess. Changes in etiology, management, and outcome. Medicine (Baltimore). 1996;75(2):99-113.
    doi
  12. Kadoya M, Matsui O, Takashima T, Nonomura A. Hepatocellular carcinoma: correlation of MR imaging and histopathologic findings. Radiology. 1992;183(3):819-825.
    doi pubmed
  13. Fowler KJ, Saad NE, Linehan D. Imaging approach to hepatocellular carcinoma, cholangiocarcinoma, and metastatic colorectal cancer. Surg Oncol Clin N Am. 2015;24(1):19-40.
    doi pubmed
  14. Chung YF, Thng CH, Lui HF, Mancer K, Chow PK, Tan YM, Cheow PC, et al. Clinical mimicry of hepatocellular carcinoma: imaging-pathological correlation. Singapore Med J. 2005;46(1):31-36; quiz 37.
    pubmed
  15. Nagano K, Fukuda Y, Nakano I, Katano Y, Toyoda H, Ebata M, Morita K, et al. An autopsy case of multilocular cystic hepatocellular carcinoma without liver cirrhosis. Hepatogastroenterology. 2000;47(35):1419-1421.
    pubmed
  16. Chung YE, Kim MJ, Park YN, Choi JY, Pyo JY, Kim YC, Cho HJ, et al. Varying appearances of cholangiocarcinoma: radiologic-pathologic correlation. Radiographics. 2009;29(3):683-700.
    doi pubmed
  17. Yazici C, Niemeyer DJ, Iannitti DA, Russo MW. Hepatocellular carcinoma and cholangiocarcinoma: an update. Expert Rev Gastroenterol Hepatol. 2014;8(1):63-82.
    doi pubmed
  18. Shindoh J, Loyer EM, Kopetz S, Boonsirikamchai P, Maru DM, Chun YS, Zimmitti G, et al. Optimal morphologic response to preoperative chemotherapy: an alternate outcome end point before resection of hepatic colorectal metastases. J Clin Oncol. 2012;30(36):4566-4572.
    doi pubmed
  19. Lin YT, Liu CJ, Chen TJ, Chen TL, Yeh YC, Wu HS, Tseng CP, et al. Pyogenic liver abscess as the initial manifestation of underlying hepatocellular carcinoma. Am J Med. 2011;124(12):1158-1164.
    doi pubmed
  20. Li C, Li G, Miao R, Lu X, Zhong S, Sang X, Mao Y, et al. Primary liver cancer presenting as pyogenic liver abscess: characteristics, diagnosis, and management. J Surg Oncol. 2012;105(7):687-691.
    doi pubmed
  21. Barr Fritcher EG, Voss JS, Jenkins SM, Lingineni RK, Clayton AC, Roberts LR, Halling KC, et al. Primary sclerosing cholangitis with equivocal cytology: fluorescence in situ hybridization and serum CA 19-9 predict risk of malignancy. Cancer Cytopathol. 2013;121(12):708-717.
    doi pubmed
  22. Okuda K, Kondo Y, Nakano M, Kage M, Arakawa M, Kojiro M, Ohtsuki T, et al. Hepatocellular carcinoma presenting with pyrexia and leukocytosis: report of five cases. Hepatology. 1991;13(4):695-700.
    doi pubmed
  23. Takayasu K, Okuda K. Imaging in Liver Disease: From Diagnosis to Treatment. New York: Oxford University Press. 1997:299-307.


This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


Journal of Medical Cases is published by Elmer Press Inc.

 

Browse  Journals  

     

Journal of clinical Medicine Research

Journal of Endocrinology and Metabolism

Journal of Clinical Gynecology and Obstetrics

World Journal of Oncology

Gastroenterology Research

Journal of Hematology

Journal of Medical Cases

Journal of Current Surgery

Clinical Infection and Immunity

Cardiology Research

World Journal of Nephrology and Urology

Cellular and Molecular Medicine Research

Journal of Neurology Research

International Journal of Clinical Pediatrics

 

 

 

 

 

Journal of Medical Cases, monthly, ISSN 1923-4155 (print), 1923-4163 (online), published by Elmer Press Inc.            
The content of this site is intended for health care professionals.
This is an open-access journal distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License, which permits unrestricted
non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Creative Commons Attribution license (Attribution-NonCommercial 4.0 International CC-BY-NC 4.0)


This journal follows the International Committee of Medical Journal Editors (ICMJE) recommendations for manuscripts submitted to biomedical journals,
the Committee on Publication Ethics (COPE) guidelines, and the Principles of Transparency and Best Practice in Scholarly Publishing.

website: www.journalmc.org   editorial contact: editor@journalmc.org
Address: 9225 Leslie Street, Suite 201, Richmond Hill, Ontario, L4B 3H6, Canada

© Elmer Press Inc. All Rights Reserved.